1. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J. China National Diabetes and Metabolic Disorders Study Group. 2010; Prevalence of diabetes among men and women in China. N Engl J Med. 362:1090–1101. DOI:
10.1056/NEJMoa0908292. PMID:
20335585.
Article
2. He X, Yang Y, Yao MW, Ren TT, Guo W, Li L, Xu X. 2019; Full title: High glucose protects mesenchymal stem cells from metformin-induced apoptosis through the AMPK-mediated mTOR pathway. Sci Rep. 9:17764. DOI:
10.1038/s41598-019-54291-y. PMID:
31780804. PMCID:
PMC6882892.
Article
4. Cho J, D'Antuono M, Glicksman M, Wang J, Jonklaas J. 2018; A review of clinical trials: mesenchymal stem cell transplant therapy in type 1 and type 2 diabetes mellitus. Am J Stem Cells. 7:82–93. PMID:
30510843. PMCID:
PMC6261870.
6. Ying W, Fu W, Lee YS, Olefsky JM. 2020; The role of macrophages in obesity-associated islet inflammation and
β-cell abnormalities. Nat Rev Endocrinol. 16:81–90. DOI:
10.1038/s41574-019-0286-3. PMID:
31836875.
Article
8. Samsonraj RM, Raghunath M, Nurcombe V, Hui JH, van Wijnen AJ, Cool SM. 2017; Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Transl Med. 6:2173–2185. DOI:
10.1002/sctm.17-0129. PMID:
29076267. PMCID:
PMC5702523.
Article
9. Zhang L, Wang H, Liu C, Wu Q, Su P, Wu D, Guo J, Zhou W, Xu Y, Shi L, Zhou J. 2018; MSX2 Initiates and accelerates mesenchymal stem/stromal cell specification of hPSCs by regulating TWIST1 and PRAME. Stem Cell Reports. 11:497–513. DOI:
10.1016/j.stemcr.2018.06.019. PMID:
30033084. PMCID:
PMC6092836.
Article
10. Zhao Q, Zhang L, Wei Y, Yu H, Zou L, Huo J, Yang H, Song B, Wei T, Wu D, Zhang W, Zhang L, Liu D, Li Z, Chi Y, Han Z, Han Z. 2019; Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease. Stem Cell Res Ther. 10:354. DOI:
10.1186/s13287-019-1478-4. PMID:
31779707. PMCID:
PMC6883552.
Article
11. Kabat M, Bobkov I, Kumar S, Grumet M. 2020; Trends in mesenchymal stem cell clinical trials 2004-2018: is efficacy optimal in a narrow dose range? Stem Cells Transl Med. 9:17–27. DOI:
10.1002/sctm.19-0202. PMID:
31804767. PMCID:
PMC6954709.
Article
12. Shi Y, Wang Y, Li Q, Liu K, Hou J, Shao C, Wang Y. 2018; Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 14:493–507. DOI:
10.1038/s41581-018-0023-5. PMID:
29895977.
Article
13. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. 1968; Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 6:230–247. DOI:
10.1097/00007890-196803000-00009. PMID:
5654088.
14. Wei Y, Hou H, Zhang L, Zhao N, Li C, Huo J, Liu Y, Zhang W, Li Z, Liu D, Han Z, Zhang L, Song B, Chi Y, Han Z. 2019; JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia. Stem Cell Res Ther. 10:186. DOI:
10.1186/s13287-019-1302-1. PMID:
31234947. PMCID:
PMC6591900.
Article
15. Zhang X, Yang Y, Zhang L, Lu Y, Zhang Q, Fan D, Zhang Y, Zhang Y, Ye Z, Xiong D. 2017; Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan. J Hematol Oncol. 10:56. DOI:
10.1186/s13045-017-0397-z. PMID:
28228105. PMCID:
PMC5322661.
Article
16. Yao J, Chen N, Wang X, Zhang L, Huo J, Chi Y, Li Z, Han Z. 2020; Human supernumerary teeth-derived apical papillary stem cells possess preferable characteristics and efficacy on hepatic fibrosis in mice. Stem Cells Int. 2020:6489396. DOI:
10.1155/2020/6489396. PMID:
32399047. PMCID:
PMC7204141.
Article
17. Pourgholaminejad A, Aghdami N, Baharvand H, Moazzeni SM. 2016; The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells. Cytokine. 85:51–60. DOI:
10.1016/j.cyto.2016.06.003. PMID:
27288632.
Article
18. McGonagle D, Baboolal TG, Jones E. 2017; Native joint-resident mesenchymal stem cells for cartilage repair in osteoarthritis. Nat Rev Rheumatol. 13:719–730. DOI:
10.1038/nrrheum.2017.182. PMID:
29118440.
Article
20. Nombela-Arrieta C, Ritz J, Silberstein LE. 2011; The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol. 12:126–131. DOI:
10.1038/nrm3049. PMID:
21253000. PMCID:
PMC3346289.
Article
21. He Y, Xu LL, Feng FE, Wang QM, Zhu XL, Wang CC, Zhang JM, Fu HX, Xu LP, Liu KY, Huang XJ, Zhang XH. 2018; Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia. Br J Haematol. 180:395–411. DOI:
10.1111/bjh.15034. PMID:
29327472.
Article
22. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. 2003; Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 112:1796–1808. DOI:
10.1172/JCI200319246. PMID:
14679176. PMCID:
PMC296995.
Article
23. Wang L, Liu T, Liang R, Wang G, Liu Y, Zou J, Liu N, Zhang B, Liu Y, Ding X, Cai X, Wang Z, Xu X, Ricordi C, Wang S, Shen Z. 2020; Mesenchymal stem cells ameliorate
β cell dysfunction of human type 2 diabetic islets by reversing
β cell dedifferentiation. EBioMedicine. 51:102615. DOI:
10.1016/j.ebiom.2019.102615. PMID:
31918404. PMCID:
PMC7000334.
24. Kočí Z, Turnovcová K, Dubský M, Baranovičová L, Holáň V, Chudíčková M, Syková E, Kubinová S. 2014; Characterization of human adipose tissue-derived stromal cells isolated from diabetic patient's distal limbs with critical ischemia. Cell Biochem Funct. 32:597–604. DOI:
10.1002/cbf.3056. PMID:
25251698.
Article
25. Barbagallo I, Li Volti G, Galvano F, Tettamanti G, Pluchinotta FR, Bergante S, Vanella L. 2017; Diabetic human adipose tissue-derived mesenchymal stem cells fail to differentiate in functional adipocytes. Exp Biol Med (Maywood). 242:1079–1085. DOI:
10.1177/1535370216681552. PMID:
27909015. PMCID:
PMC5444636.
Article
26. Alicka M, Major P, Wysocki M, Marycz K. 2019; Adipose-derived mesenchymal stem cells isolated from patients with type 2 diabetes show reduced "stemness" through an altered secretome profile, impaired anti-oxidative protection, and mitochondrial dynamics deterioration. J Clin Med. 8:765. DOI:
10.3390/jcm8060765. PMID:
31151180. PMCID:
PMC6617220.
Article
27. Lim M, Wang W, Liang L, Han ZB, Li Z, Geng J, Zhao M, Jia H, Feng J, Wei Z, Song B, Zhang J, Li J, Liu T, Wang F, Li T, Li J, Fang Y, Gao J, Han Z. 2018; Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction. Stem Cell Res Ther. 9:129. DOI:
10.1186/s13287-018-0888-z. PMID:
29751831. PMCID:
PMC5948807.
Article
28. Zhang L, Liu C, Wang H, Wu D, Su P, Wang M, Guo J, Zhao S, Dong S, Zhou W, Arakaki C, Zhang X, Zhou J. 2018; Thrombopoietin knock-in augments platelet generation from human embryonic stem cells. Stem Cell Res Ther. 9:194. DOI:
10.1186/s13287-018-0926-x. PMID:
30016991. PMCID:
PMC6050740.
Article
29. Pachón-Peña G, Serena C, Ejarque M, Petriz J, Duran X, Oliva-Olivera W, Simó R, Tinahones FJ, Fernández-Veledo S, Vendrell J. 2016; Obesity determines the immunophenotypic profile and functional characteristics of human mesenchymal stem cells from adipose tissue. Stem Cells Transl Med. 5:464–475. DOI:
10.5966/sctm.2015-0161. PMID:
26956208. PMCID:
PMC4798735.
Article
30. Serena C, Keiran N, Ceperuelo-Mallafre V, Ejarque M, Fradera R, Roche K, Nuñez-Roa C, Vendrell J, Fernández-Veledo S. 2016; Obesity and type 2 diabetes alters the immune properties of human adipose derived stem cells. Stem Cells. 34:2559–2573. DOI:
10.1002/stem.2429. PMID:
27352919.
Article
31. Kornicka K, Houston J, Marycz K. 2018; Dysfunction of mesenchymal stem cells isolated from metabolic syndrome and type 2 diabetic patients as result of oxidative stress and autophagy may limit their potential therapeutic use. Stem Cell Rev Rep. 14:337–345. DOI:
10.1007/s12015-018-9809-x. PMID:
29611042. PMCID:
PMC5960487.
Article
32. Hankamolsiri W, Manochantr S, Tantrawatpan C, Tantikanlayaporn D, Tapanadechopone P, Kheolamai P. 2016; The effects of high glucose on adipogenic and osteogenic differentiation of gestational tissue-derived MSCs. Stem Cells Int. 2016:9674614. DOI:
10.1155/2016/9674614. PMID:
27057179. PMCID:
PMC4707328.
Article
33. Lafosse A, Dufeys C, Beauloye C, Horman S, Dufrane D. 2016; Impact of hyperglycemia and low oxygen tension on adipose-derived stem cells compared with dermal fibroblasts and keratinocytes: importance for wound healing in type 2 diabetes. PLoS One. 11:e0168058. DOI:
10.1371/journal.pone.0168058. PMID:
27992567. PMCID:
PMC5167273.
Article
34. Krishnan B, Sallam HS, Tumurbataar B, Saieva S, Baymon D, Tuvdendorj D, Micci MA, Abate N, Taglialatela G. 2020; Amelioration of hippocampal dysfunction by adipose tissue-targeted stem cell transplantation in a mouse model of type 2 diabetes. J Neurochem. 153:51–62. DOI:
10.1111/jnc.14915. PMID:
31730234.
Article
38. Cornu M, Thorens B. 2009; GLP-1 protects
β-cells against apoptosis by enhancing the activity of an IGF-2/IGF1-receptor autocrine loop. Islets. 1:280–282. DOI:
10.4161/isl.1.3.9932. PMID:
21099285.
Article
39. Gaddy DF, Riedel MJ, Pejawar-Gaddy S, Kieffer TJ, Robbins PD. 2010; In vivo expression of HGF/NK1 and GLP-1 from dsAAV vectors enhances pancreatic ß-cell proliferation and improves pathology in the db/db mouse model of diabetes. Diabetes. 59:3108–3116. DOI:
10.2337/db09-1886. PMID:
20841608. PMCID:
PMC2992772.
Article